David E Kaplan Selected Research

David E Kaplan Research Topics

Disease

42	Fibrosis (Cirrhosis) 12/2023 - 06/2008
33	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 08/2003
17	Infections 01/2023 - 06/2005
15	Neoplasms (Cancer) 01/2023 - 08/2003
14	Liver Diseases (Liver Disease) 01/2023 - 10/2017
9	End Stage Liver Disease 01/2022 - 11/2017
7	COVID-19 01/2023 - 01/2022
6	Hepatitis C 10/2020 - 08/2003
5	Hemorrhage 01/2022 - 12/2019
4	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2020
4	Liver Neoplasms (Liver Cancer) 01/2021 - 11/2017
3	Viremia 01/2023 - 06/2008
3	Chronic Hepatitis C 10/2022 - 06/2005
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2020
3	Ascites 10/2021 - 12/2015
3	Portal Hypertension 01/2021 - 01/2021
3	Hepatitis B 01/2019 - 08/2003
2	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 06/2020
2	Fatty Liver 01/2024 - 01/2021
2	Acute-On-Chronic Liver Failure 06/2023 - 01/2022
2	Ischemic Stroke 10/2021 - 01/2021
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 08/2021 - 01/2021
2	Virus Diseases (Viral Diseases) 11/2017 - 06/2008
2	Persistent Infection 12/2015 - 06/2008
2	Chronic Hepatitis (Chronic Active Hepatitis) 06/2008 - 08/2003
1	Pancreatic Cyst 01/2024
1	Gallstones (Gallstone) 01/2024
1	Adenocarcinoma 10/2023
1	Alcoholism (Alcohol Abuse) 01/2023
1	Alcoholic Hepatitis 01/2022
1	Genetic Risk Score 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	Coronary Disease (Coronary Heart Disease) 10/2021
1	Diabetes Mellitus 10/2021
1	Thrombosis (Thrombus) 01/2021

Drug/Important Bio-Agent (IBA)

9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2023 - 08/2018
8	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 11/2017
8	Antiviral Agents (Antivirals)IBA 10/2022 - 06/2005
8	SodiumIBA 01/2022 - 11/2017
7	VaccinesIBA 01/2023 - 08/2003
7	Cytidine Triphosphate (CTP)IBA 01/2023 - 12/2015
5	Alanine Transaminase (SGPT)IBA 04/2024 - 04/2015
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2012
4	AntigensIBA 01/2021 - 06/2005
3	BilirubinIBA 01/2024 - 01/2021
3	mRNA VaccinesIBA 01/2023 - 10/2022
3	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2023 - 01/2021
3	Messenger RNA (mRNA)IBA 11/2022 - 06/2020
3	Peptides (Polypeptides)IBA 06/2020 - 06/2008
3	InterferonsIBA 01/2016 - 09/2011
3	GlypicansIBA 05/2015 - 06/2011
2	AlbuminsIBA 01/2024 - 01/2021
2	NivolumabIBA 01/2023 - 10/2019
2	BNT162 VaccineIBA 11/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2015
2	Metformin (Glucophage)FDA LinkGeneric 10/2021 - 10/2021
2	EnzymesIBA 10/2021 - 06/2008
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2016
2	Hepatitis B e AntigensIBA 10/2020 - 01/2016
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2017 - 01/2016
2	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 09/2011
2	Interferon-gamma (Interferon, gamma)IBA 06/2011 - 02/2007
2	CytokinesIBA 07/2009 - 06/2008
1	TransferasesIBA 04/2024
1	Alkaline PhosphataseIBA 01/2024
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2024
1	Triglycerides (Triacylglycerol)IBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	Blood Glucose (Blood Sugar)IBA 12/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2023
1	Carvedilol (Coreg)FDA LinkGeneric 01/2023
1	Naltrexone (ReVia)FDA LinkGeneric 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	Acamprosate (Campral)FDA Link 01/2023
1	2019-nCoV Vaccine mRNA-1273IBA 11/2022
1	NucleotidesIBA 01/2022
1	Ranitidine (Zantac)FDA LinkGeneric 01/2022
1	Proton Pumps (Proton Pump)IBA 01/2022
1	O(4)-methylthymidine triphosphateIBA 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	AcidsIBA 01/2022
1	Apoptosis Regulatory ProteinsIBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2021
1	AngiotensinogenIBA 10/2021
1	AngiotensinsIBA 10/2021
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 10/2021
1	Sodium-Glucose Transport ProteinsIBA 10/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2021
1	obeticholic acidIBA 08/2021

Therapy/Procedure

21	Therapeutics 06/2023 - 08/2003
8	Liver Transplantation 01/2023 - 01/2018
6	Transplantation 08/2021 - 08/2003
4	Aftercare (After-Treatment) 01/2021 - 11/2017
3	Operative Surgical Procedures 01/2021 - 01/2019
1	Glycemic Control 12/2023
1	Gastrectomy 01/2023
1	Ambulatory Care (Outpatient Care) 11/2022
1	Transjugular Intrahepatic Portasystemic Shunt 01/2022
1	Precision Medicine 11/2021
1	Drug Therapy (Chemotherapy) 10/2021